(Q44164630)

30 November 2017

title

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries (English)

1 reference

30 November 2017

main subject

cervix uterine cancer

1 reference

1

Jeanne S Mandelblatt

1 reference

30 November 2017

William F Lawrence

2

1 reference

30 November 2017

Lynne Gaffikin

3

1 reference

30 November 2017

Khunying Kobchitt Limpahayom

4

1 reference

30 November 2017

Pisake Lumbiganon

5

1 reference

30 November 2017

Suwanna Warakamin

6

1 reference

30 November 2017

Jason King

7

1 reference

30 November 2017

Bin Yi

8

1 reference

30 November 2017

Patricia Ringers

9

1 reference

30 November 2017

Paul D Blumenthal

10

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of the National Cancer Institute

30 November 2017

published in

1 reference

30 November 2017

volume

94

1 reference

30 November 2017

issue

19

1 reference

30 November 2017

page(s)

1469-1483

1 reference

Analysis of lifestyle data and cytologic findings in a pilot cervical screening project in rural Vietnam

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Can papilloma virus testing be used to improve cervical cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

HIV-1 seroprevalence among childbearing women in northern Thailand: monitoring a rapidly evolving epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Natural history of cervical neoplasia: overview and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Epidemiology of Genital Human Papillomavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

The Markov process in medical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

The relationship of human papillomavirus (HPV) detection to pap smear classification of cervical-scraped cells in asymptomatic women in northeast Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Determinants of persistent detection of human papillomavirus DNA in the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

One-session management of cervical intraepithelial neoplasia: a solution for developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Meta-analysis of Pap test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Impact of therapy for cervical intraepithelial neoplasia on fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Detection of cervical intraepithelial neoplasia in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Can cervical cancer be prevented by a see, screen, and treat program? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

A mobile unit: an effective service for cervical cancer screening among rural Thai women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

Risk Factors for Cervical Cancer in Thailand: a Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.19.1469

21 January 2018

Identifiers

DOI

10.1093/JNCI/94.19.1469

1 reference

30 November 2017

1 reference